Reports / Type 2 Diabetes Market

Type 2 Diabetes Market

Type 2 Diabetes Market Research Report – Segmented By Drug Class (ALPHA-GLUCOSIDASE INHIBITORS, BIGUANIDES, DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS, GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS, SODIUM–GLUCOSE COTRANSPORTER 2 INHIBITORS, SULFONYLUREAS & OTHER INSULIN SECRETAGOGUES, THIAZOLIDINEDIONES), Application (CARDIOVASCULAR SAFETY, GLYCEMIC CONTROL, HYPOGLYCEMIA AVOIDANCE, OTHERS), Region (ASIA-PACIFIC, EUROPE, LAMEA, NORTH AMERICA) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2017 to 2026.

Executive Summary

Type 2 Diabetes Market Size, 2019-2027 (USD Million)

Report Metric	Details
Market size available for years	2012-2027
Base year considered	2021
Forecast period	2022-2027
Forecast units	Value (USD Billion)
Segments covered	Drug Class, Application, Region
Geographies covered	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Companies Covered	ELI LILLY AND CO., SANOFI AVENTIS A/S, NOVO NORDISK, MERCK & CO., INC., CHUGAI PHARMACEUTICAL CO., BRISTOL-MYERS SQUIBB, PFIZER INC., BAYER AG, GLAXOSMITHKLINE PLC., ASTRAZENECA PLC

Type 2 Diabetes Market from Consainsights analyses the Type 2 Diabetes Market in the Life Sciences industry over the forecast period to 2026.

Type 2 Diabetes research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Type 2 Diabetes segmentation includes Drug Class, Application, Region and Geography.

All segmentations encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the Drug Class, the Type 2 Diabetes Market analysis covers ALPHA-GLUCOSIDASE INHIBITORS, BIGUANIDES, DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS, GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS, SODIUM–GLUCOSE COTRANSPORTER 2 INHIBITORS, SULFONYLUREAS & OTHER INSULIN SECRETAGOGUES, THIAZOLIDINEDIONES.

Based on the Application, the Type 2 Diabetes Market analysis covers CARDIOVASCULAR SAFETY, GLYCEMIC CONTROL, HYPOGLYCEMIA AVOIDANCE, OTHERS.

Based on the Region, the Type 2 Diabetes Market analysis covers ASIA-PACIFIC, EUROPE, LAMEA, NORTH AMERICA.

Key companies operating in the market include ELI LILLY AND CO., SANOFI AVENTIS A/S, NOVO NORDISK, MERCK & CO., INC., CHUGAI PHARMACEUTICAL CO., BRISTOL-MYERS SQUIBB, PFIZER INC., BAYER AG, GLAXOSMITHKLINE PLC., ASTRAZENECA PLC and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

Revenue Share (%), By Drug Class (2019)
Revenue Share (%), By Application (2019)
Revenue Share (%), By Region (2019)

Market Overview

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

By Drug Class

By Drug Class, The Global Type 2 Diabetes Market analysis covers ALPHA-GLUCOSIDASE INHIBITORS, BIGUANIDES, DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS, GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS, SODIUM–GLUCOSE COTRANSPORTER 2 INHIBITORS, SULFONYLUREAS & OTHER INSULIN SECRETAGOGUES, THIAZOLIDINEDIONES.

The ALPHA-GLUCOSIDASE INHIBITORS segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

ALPHA-GLUCOSIDASE INHIBITORS: Global Type 2 Diabetes Market Revenue Opportunity (Us$ Mn)

The BIGUANIDES segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

BIGUANIDES: Global Type 2 Diabetes Market Revenue Opportunity (Us$ Mn)

The DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS: Global Type 2 Diabetes Market Revenue Opportunity (Us$ Mn)

The GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS: Global Type 2 Diabetes Market Revenue Opportunity (Us$ Mn)

The SODIUM–GLUCOSE COTRANSPORTER 2 INHIBITORS segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

SODIUM–GLUCOSE COTRANSPORTER 2 INHIBITORS: Global Type 2 Diabetes Market Revenue Opportunity (Us$ Mn)

The SULFONYLUREAS & OTHER INSULIN SECRETAGOGUES segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

SULFONYLUREAS & OTHER INSULIN SECRETAGOGUES: Global Type 2 Diabetes Market Revenue Opportunity (Us$ Mn)

The THIAZOLIDINEDIONES segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

THIAZOLIDINEDIONES: Global Type 2 Diabetes Market Revenue Opportunity (Us$ Mn)

By Application

By Application, The Global Type 2 Diabetes Market analysis covers CARDIOVASCULAR SAFETY, GLYCEMIC CONTROL, HYPOGLYCEMIA AVOIDANCE, OTHERS.

The CARDIOVASCULAR SAFETY segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

CARDIOVASCULAR SAFETY: Global Type 2 Diabetes Market Revenue Opportunity (Us$ Mn)

The GLYCEMIC CONTROL segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

GLYCEMIC CONTROL: Global Type 2 Diabetes Market Revenue Opportunity (Us$ Mn)

The HYPOGLYCEMIA AVOIDANCE segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

HYPOGLYCEMIA AVOIDANCE: Global Type 2 Diabetes Market Revenue Opportunity (Us$ Mn)

The OTHERS segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

OTHERS: Global Type 2 Diabetes Market Revenue Opportunity (Us$ Mn)

By Region

By Region, The Global Type 2 Diabetes Market analysis covers ASIA-PACIFIC, EUROPE, LAMEA, NORTH AMERICA.

The ASIA-PACIFIC segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

ASIA-PACIFIC: Global Type 2 Diabetes Market Revenue Opportunity (Us$ Mn)

The EUROPE segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

EUROPE: Global Type 2 Diabetes Market Revenue Opportunity (Us$ Mn)

The LAMEA segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

LAMEA: Global Type 2 Diabetes Market Revenue Opportunity (Us$ Mn)

The NORTH AMERICA segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

North America

Based on the North America, the Type 2 Diabetes Market analysis covers United States, Canada.

North America Type 2 Diabetes Size, 2019-2027 (Us$ Mn) — North America Type 2 Diabetes Market Size, 2019-2027 (Us$ Mn)

North America Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

North America Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

United States Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

United States Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Canada Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Canada Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Europe

Based on the Europe, the Type 2 Diabetes Market analysis covers Germany, United Kingdom, France, Spain, Russia, Italy, Rest of Europe.

Europe Type 2 Diabetes Size, 2019-2027 (Us$ Mn) — Europe Type 2 Diabetes Market Size, 2019-2027 (Us$ Mn)

Europe Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Europe Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Germany Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Germany Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

United Kingdom Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

United Kingdom Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

France Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

France Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Spain Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Spain Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Russia Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Russia Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Italy Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Italy Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Rest of Europe Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Rest of Europe Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Asia-Pacific

Based on the Asia-Pacific, the Type 2 Diabetes Market analysis covers China, Japan, India, Southeast Asia, Australia & New Zealand, Rest of Asia-Pacific.

Asia-Pacific Type 2 Diabetes Size, 2019-2027 (Us$ Mn) — Asia-Pacific Type 2 Diabetes Market Size, 2019-2027 (Us$ Mn)

Asia-Pacific Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Asia-Pacific Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

China Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

China Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Japan Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Japan Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

India Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

India Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Southeast Asia Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Southeast Asia Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Australia & New Zealand Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Australia & New Zealand Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Rest of Asia-Pacific Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Rest of Asia-Pacific Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Middle East & Africa

Based on the Middle East & Africa, the Type 2 Diabetes Market analysis covers Middle East, Africa, Rest of Middle East & Africa.

Middle East & Africa Type 2 Diabetes Size, 2019-2027 (Us$ Mn) — Middle East & Africa Type 2 Diabetes Market Size, 2019-2027 (Us$ Mn)

Middle East & Africa Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Middle East & Africa Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Middle East Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Middle East Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Africa Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Africa Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Rest of Middle East & Africa Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Rest of Middle East & Africa Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Latin America

Based on the Latin America, the Type 2 Diabetes Market analysis covers Brazil, Argentina, Mexico, Colombia, Rest of Latin America.

Latin America Type 2 Diabetes Size, 2019-2027 (Us$ Mn) — Latin America Type 2 Diabetes Market Size, 2019-2027 (Us$ Mn)

Latin America Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Latin America Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Brazil Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Brazil Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Argentina Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Argentina Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Mexico Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Mexico Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Colombia Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Colombia Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Rest of Latin America Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Drug Class, 2019-2027

Rest of Latin America Type 2 Diabetes Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027

Company Analysis

ELI LILLY AND CO.
SANOFI AVENTIS A/S
NOVO NORDISK
MERCK & CO., INC.
CHUGAI PHARMACEUTICAL CO.
BRISTOL-MYERS SQUIBB
PFIZER INC.
BAYER AG
GLAXOSMITHKLINE PLC.
ASTRAZENECA PLC

Chapters

Executive Summary
Type 2 Diabetes Market Overview
1. Type 2 Diabetes Market Definition & Scope
2. Currency, Year and Forecasts Overview
3. Type 2 Diabetes Market 360° Synopsis: Overview
Type 2 Diabetes Industry Analysis
1. Industry Value Chain Analysis
2. Key Companies at each phase of Value Chain
3. Industry Trend Analysis
Type 2 Diabetes Market Analysis
1. Drives, Restraints, Opportunities and Challenges Impact Analysis
2. Porter’s Five Force Model Analysis
3. PESTLE Analysis
4. BPS Analysis
5. Type 2 Diabetes Market Key Innovation & Trends
6. Pricing Patterns (Company & Product Type)
Type 2 Diabetes Market: Drug Class
1. Introduction
2. ALPHA-GLUCOSIDASE INHIBITORS: Market Trends, Size, and Forecast (2017-2026)
3. BIGUANIDES: Market Trends, Size, and Forecast (2017-2026)
4. DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS: Market Trends, Size, and Forecast (2017-2026)
5. GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS: Market Trends, Size, and Forecast (2017-2026)
6. SODIUM–GLUCOSE COTRANSPORTER 2 INHIBITORS: Market Trends, Size, and Forecast (2017-2026)
7. SULFONYLUREAS & OTHER INSULIN SECRETAGOGUES: Market Trends, Size, and Forecast (2017-2026)
8. THIAZOLIDINEDIONES: Market Trends, Size, and Forecast (2017-2026)
Type 2 Diabetes Market: Application
1. Introduction
2. CARDIOVASCULAR SAFETY: Market Trends, Size, and Forecast (2017-2026)
3. GLYCEMIC CONTROL: Market Trends, Size, and Forecast (2017-2026)
4. HYPOGLYCEMIA AVOIDANCE: Market Trends, Size, and Forecast (2017-2026)
5. OTHERS: Market Trends, Size, and Forecast (2017-2026)
Type 2 Diabetes Market: Region
1. Introduction
2. ASIA-PACIFIC: Market Trends, Size, and Forecast (2017-2026)
3. EUROPE: Market Trends, Size, and Forecast (2017-2026)
4. LAMEA: Market Trends, Size, and Forecast (2017-2026)
5. NORTH AMERICA: Market Trends, Size, and Forecast (2017-2026)
Global Analysis
1. Global Type 2 Diabetes Market, By Region, Y-O-Y Growth Analysis
  1. Introduction
  2. North America: Market Trends, Size, and Forecast (2017-2026)
  3. Europe: Market Trends, Size, and Forecast (2017-2026)
  4. Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)
  5. Latin America: Market Trends, Size, and Forecast (2017-2026)
  6. Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)
North America Analysis
1. North America Type 2 Diabetes Market, By Country, Y-O-Y Growth Analysis
  1. Introduction
  2. United States: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. United States Type 2 Diabetes Market: Drug Class
    3. United States Type 2 Diabetes Market: Application
    4. United States Type 2 Diabetes Market: Region
  3. Canada: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. Canada Type 2 Diabetes Market: Drug Class
    3. Canada Type 2 Diabetes Market: Application
    4. Canada Type 2 Diabetes Market: Region
2. North America Type 2 Diabetes Market, By Drug Class, Y-O-Y Growth Analysis
  1. Introduction
  2. ALPHA-GLUCOSIDASE INHIBITORS: Market Trends, Size, and Forecast (2017-2026)
  3. BIGUANIDES: Market Trends, Size, and Forecast (2017-2026)
  4. DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS: Market Trends, Size, and Forecast (2017-2026)
  5. GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS: Market Trends, Size, and Forecast (2017-2026)
  6. SODIUM–GLUCOSE COTRANSPORTER 2 INHIBITORS: Market Trends, Size, and Forecast (2017-2026)
  7. SULFONYLUREAS & OTHER INSULIN SECRETAGOGUES: Market Trends, Size, and Forecast (2017-2026)
  8. THIAZOLIDINEDIONES: Market Trends, Size, and Forecast (2017-2026)
3. North America Type 2 Diabetes Market, By Application, Y-O-Y Growth Analysis
  1. Introduction
  2. CARDIOVASCULAR SAFETY: Market Trends, Size, and Forecast (2017-2026)
  3. GLYCEMIC CONTROL: Market Trends, Size, and Forecast (2017-2026)
  4. HYPOGLYCEMIA AVOIDANCE: Market Trends, Size, and Forecast (2017-2026)
  5. OTHERS: Market Trends, Size, and Forecast (2017-2026)
4. North America Type 2 Diabetes Market, By Region, Y-O-Y Growth Analysis
  1. Introduction
  2. ASIA-PACIFIC: Market Trends, Size, and Forecast (2017-2026)
  3. EUROPE: Market Trends, Size, and Forecast (2017-2026)
  4. LAMEA: Market Trends, Size, and Forecast (2017-2026)
  5. NORTH AMERICA: Market Trends, Size, and Forecast (2017-2026)
Europe Analysis
1. Europe Type 2 Diabetes Market, By Country, Y-O-Y Growth Analysis
  1. Introduction
  2. Germany: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. Germany Type 2 Diabetes Market: Drug Class
    3. Germany Type 2 Diabetes Market: Application
    4. Germany Type 2 Diabetes Market: Region
  3. United Kingdom: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. United Kingdom Type 2 Diabetes Market: Drug Class
    3. United Kingdom Type 2 Diabetes Market: Application
    4. United Kingdom Type 2 Diabetes Market: Region
  4. France: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. France Type 2 Diabetes Market: Drug Class
    3. France Type 2 Diabetes Market: Application
    4. France Type 2 Diabetes Market: Region
  5. Spain: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. Spain Type 2 Diabetes Market: Drug Class
    3. Spain Type 2 Diabetes Market: Application
    4. Spain Type 2 Diabetes Market: Region
  6. Russia: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. Russia Type 2 Diabetes Market: Drug Class
    3. Russia Type 2 Diabetes Market: Application
    4. Russia Type 2 Diabetes Market: Region
  7. Italy: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. Italy Type 2 Diabetes Market: Drug Class
    3. Italy Type 2 Diabetes Market: Application
    4. Italy Type 2 Diabetes Market: Region
  8. Rest of Europe: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. Rest of Europe Type 2 Diabetes Market: Drug Class
    3. Rest of Europe Type 2 Diabetes Market: Application
    4. Rest of Europe Type 2 Diabetes Market: Region
2. Europe Type 2 Diabetes Market, By Drug Class, Y-O-Y Growth Analysis
  1. Introduction
  2. ALPHA-GLUCOSIDASE INHIBITORS: Market Trends, Size, and Forecast (2017-2026)
  3. BIGUANIDES: Market Trends, Size, and Forecast (2017-2026)
  4. DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS: Market Trends, Size, and Forecast (2017-2026)
  5. GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS: Market Trends, Size, and Forecast (2017-2026)
  6. SODIUM–GLUCOSE COTRANSPORTER 2 INHIBITORS: Market Trends, Size, and Forecast (2017-2026)
  7. SULFONYLUREAS & OTHER INSULIN SECRETAGOGUES: Market Trends, Size, and Forecast (2017-2026)
  8. THIAZOLIDINEDIONES: Market Trends, Size, and Forecast (2017-2026)
3. Europe Type 2 Diabetes Market, By Application, Y-O-Y Growth Analysis
  1. Introduction
  2. CARDIOVASCULAR SAFETY: Market Trends, Size, and Forecast (2017-2026)
  3. GLYCEMIC CONTROL: Market Trends, Size, and Forecast (2017-2026)
  4. HYPOGLYCEMIA AVOIDANCE: Market Trends, Size, and Forecast (2017-2026)
  5. OTHERS: Market Trends, Size, and Forecast (2017-2026)
4. Europe Type 2 Diabetes Market, By Region, Y-O-Y Growth Analysis
  1. Introduction
  2. ASIA-PACIFIC: Market Trends, Size, and Forecast (2017-2026)
  3. EUROPE: Market Trends, Size, and Forecast (2017-2026)
  4. LAMEA: Market Trends, Size, and Forecast (2017-2026)
  5. NORTH AMERICA: Market Trends, Size, and Forecast (2017-2026)
Asia-Pacific Analysis
1. Asia-Pacific Type 2 Diabetes Market, By Country, Y-O-Y Growth Analysis
  1. Introduction
  2. China: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. China Type 2 Diabetes Market: Drug Class
    3. China Type 2 Diabetes Market: Application
    4. China Type 2 Diabetes Market: Region
  3. Japan: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. Japan Type 2 Diabetes Market: Drug Class
    3. Japan Type 2 Diabetes Market: Application
    4. Japan Type 2 Diabetes Market: Region
  4. India: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. India Type 2 Diabetes Market: Drug Class
    3. India Type 2 Diabetes Market: Application
    4. India Type 2 Diabetes Market: Region
  5. Southeast Asia: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. Southeast Asia Type 2 Diabetes Market: Drug Class
    3. Southeast Asia Type 2 Diabetes Market: Application
    4. Southeast Asia Type 2 Diabetes Market: Region
  6. Australia & New Zealand: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. Australia & New Zealand Type 2 Diabetes Market: Drug Class
    3. Australia & New Zealand Type 2 Diabetes Market: Application
    4. Australia & New Zealand Type 2 Diabetes Market: Region
  7. Rest of Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. Rest of Asia-Pacific Type 2 Diabetes Market: Drug Class
    3. Rest of Asia-Pacific Type 2 Diabetes Market: Application
    4. Rest of Asia-Pacific Type 2 Diabetes Market: Region
2. Asia-Pacific Type 2 Diabetes Market, By Drug Class, Y-O-Y Growth Analysis
  1. Introduction
  2. ALPHA-GLUCOSIDASE INHIBITORS: Market Trends, Size, and Forecast (2017-2026)
  3. BIGUANIDES: Market Trends, Size, and Forecast (2017-2026)
  4. DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS: Market Trends, Size, and Forecast (2017-2026)
  5. GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS: Market Trends, Size, and Forecast (2017-2026)
  6. SODIUM–GLUCOSE COTRANSPORTER 2 INHIBITORS: Market Trends, Size, and Forecast (2017-2026)
  7. SULFONYLUREAS & OTHER INSULIN SECRETAGOGUES: Market Trends, Size, and Forecast (2017-2026)
  8. THIAZOLIDINEDIONES: Market Trends, Size, and Forecast (2017-2026)
3. Asia-Pacific Type 2 Diabetes Market, By Application, Y-O-Y Growth Analysis
  1. Introduction
  2. CARDIOVASCULAR SAFETY: Market Trends, Size, and Forecast (2017-2026)
  3. GLYCEMIC CONTROL: Market Trends, Size, and Forecast (2017-2026)
  4. HYPOGLYCEMIA AVOIDANCE: Market Trends, Size, and Forecast (2017-2026)
  5. OTHERS: Market Trends, Size, and Forecast (2017-2026)
4. Asia-Pacific Type 2 Diabetes Market, By Region, Y-O-Y Growth Analysis
  1. Introduction
  2. ASIA-PACIFIC: Market Trends, Size, and Forecast (2017-2026)
  3. EUROPE: Market Trends, Size, and Forecast (2017-2026)
  4. LAMEA: Market Trends, Size, and Forecast (2017-2026)
  5. NORTH AMERICA: Market Trends, Size, and Forecast (2017-2026)
Middle East & Africa Analysis
1. Middle East & Africa Type 2 Diabetes Market, By Country, Y-O-Y Growth Analysis
  1. Introduction
  2. Middle East: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. Middle East Type 2 Diabetes Market: Drug Class
    3. Middle East Type 2 Diabetes Market: Application
    4. Middle East Type 2 Diabetes Market: Region
  3. Africa: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. Africa Type 2 Diabetes Market: Drug Class
    3. Africa Type 2 Diabetes Market: Application
    4. Africa Type 2 Diabetes Market: Region
  4. Rest of Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. Rest of Middle East & Africa Type 2 Diabetes Market: Drug Class
    3. Rest of Middle East & Africa Type 2 Diabetes Market: Application
    4. Rest of Middle East & Africa Type 2 Diabetes Market: Region
2. Middle East & Africa Type 2 Diabetes Market, By Drug Class, Y-O-Y Growth Analysis
  1. Introduction
  2. ALPHA-GLUCOSIDASE INHIBITORS: Market Trends, Size, and Forecast (2017-2026)
  3. BIGUANIDES: Market Trends, Size, and Forecast (2017-2026)
  4. DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS: Market Trends, Size, and Forecast (2017-2026)
  5. GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS: Market Trends, Size, and Forecast (2017-2026)
  6. SODIUM–GLUCOSE COTRANSPORTER 2 INHIBITORS: Market Trends, Size, and Forecast (2017-2026)
  7. SULFONYLUREAS & OTHER INSULIN SECRETAGOGUES: Market Trends, Size, and Forecast (2017-2026)
  8. THIAZOLIDINEDIONES: Market Trends, Size, and Forecast (2017-2026)
3. Middle East & Africa Type 2 Diabetes Market, By Application, Y-O-Y Growth Analysis
  1. Introduction
  2. CARDIOVASCULAR SAFETY: Market Trends, Size, and Forecast (2017-2026)
  3. GLYCEMIC CONTROL: Market Trends, Size, and Forecast (2017-2026)
  4. HYPOGLYCEMIA AVOIDANCE: Market Trends, Size, and Forecast (2017-2026)
  5. OTHERS: Market Trends, Size, and Forecast (2017-2026)
4. Middle East & Africa Type 2 Diabetes Market, By Region, Y-O-Y Growth Analysis
  1. Introduction
  2. ASIA-PACIFIC: Market Trends, Size, and Forecast (2017-2026)
  3. EUROPE: Market Trends, Size, and Forecast (2017-2026)
  4. LAMEA: Market Trends, Size, and Forecast (2017-2026)
  5. NORTH AMERICA: Market Trends, Size, and Forecast (2017-2026)
Latin America Analysis
1. Latin America Type 2 Diabetes Market, By Country, Y-O-Y Growth Analysis
  1. Introduction
  2. Brazil: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. Brazil Type 2 Diabetes Market: Drug Class
    3. Brazil Type 2 Diabetes Market: Application
    4. Brazil Type 2 Diabetes Market: Region
  3. Argentina: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. Argentina Type 2 Diabetes Market: Drug Class
    3. Argentina Type 2 Diabetes Market: Application
    4. Argentina Type 2 Diabetes Market: Region
  4. Mexico: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. Mexico Type 2 Diabetes Market: Drug Class
    3. Mexico Type 2 Diabetes Market: Application
    4. Mexico Type 2 Diabetes Market: Region
  5. Colombia: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. Colombia Type 2 Diabetes Market: Drug Class
    3. Colombia Type 2 Diabetes Market: Application
    4. Colombia Type 2 Diabetes Market: Region
  6. Rest of Latin America: Market Trends, Size, and Forecast (2017-2026)
    1. Introduction
    2. Rest of Latin America Type 2 Diabetes Market: Drug Class
    3. Rest of Latin America Type 2 Diabetes Market: Application
    4. Rest of Latin America Type 2 Diabetes Market: Region
2. Latin America Type 2 Diabetes Market, By Drug Class, Y-O-Y Growth Analysis
  1. Introduction
  2. ALPHA-GLUCOSIDASE INHIBITORS: Market Trends, Size, and Forecast (2017-2026)
  3. BIGUANIDES: Market Trends, Size, and Forecast (2017-2026)
  4. DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS: Market Trends, Size, and Forecast (2017-2026)
  5. GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS: Market Trends, Size, and Forecast (2017-2026)
  6. SODIUM–GLUCOSE COTRANSPORTER 2 INHIBITORS: Market Trends, Size, and Forecast (2017-2026)
  7. SULFONYLUREAS & OTHER INSULIN SECRETAGOGUES: Market Trends, Size, and Forecast (2017-2026)
  8. THIAZOLIDINEDIONES: Market Trends, Size, and Forecast (2017-2026)
3. Latin America Type 2 Diabetes Market, By Application, Y-O-Y Growth Analysis
  1. Introduction
  2. CARDIOVASCULAR SAFETY: Market Trends, Size, and Forecast (2017-2026)
  3. GLYCEMIC CONTROL: Market Trends, Size, and Forecast (2017-2026)
  4. HYPOGLYCEMIA AVOIDANCE: Market Trends, Size, and Forecast (2017-2026)
  5. OTHERS: Market Trends, Size, and Forecast (2017-2026)
4. Latin America Type 2 Diabetes Market, By Region, Y-O-Y Growth Analysis
  1. Introduction
  2. ASIA-PACIFIC: Market Trends, Size, and Forecast (2017-2026)
  3. EUROPE: Market Trends, Size, and Forecast (2017-2026)
  4. LAMEA: Market Trends, Size, and Forecast (2017-2026)
  5. NORTH AMERICA: Market Trends, Size, and Forecast (2017-2026)
Type 2 Diabetes Market: Company Analysis
1. Introduction
2. ELI LILLY AND CO.
  1. Overview
  2. Business Portfolio
  3. Product Portfolio
  4. Key Brands Insights
  5. Company SWOT & Strategic Analysis
  6. Company Financials
  7. Analyst Insights
3. SANOFI AVENTIS A/S
4. NOVO NORDISK
5. MERCK & CO., INC.
6. CHUGAI PHARMACEUTICAL CO.
7. BRISTOL-MYERS SQUIBB
8. PFIZER INC.
9. BAYER AG
10. GLAXOSMITHKLINE PLC.
11. ASTRAZENECA PLC
Type 2 Diabetes Market: Competitive Analysis
1. Strategic Dashboard of Top Market Players
2. Companies Deals (Mergers, Partnerships, Acquisitions, JVs)
3. Expansion Areas (Based on Company Analysis)
4. Market Share Analysis
Type 2 Diabetes Market: Distribution Channel Analysis
1. Distributor Type Analysis
2. Major Distributors (Key Countries)
3. Future Growth Prospects
Industry & Analysts Insights forSuccess
Research Methodology
Appendix
1. List of Tables
2. List of Figures
3. Available Customizations
4. Related Reports